France’s health ministry announced Thursday it had approved the use of Sativex, a cannabinoid mouth spray, to treat patients suffering from multiple sclerosis (MS). The drug is the first marijuana-based medicine to be made available in the country.The drug still has some hoops to go through but should be available in 2015.
comments to taglines82@gmail.com
